Article
Dominant-negative loss of PPARgamma function enhances smooth muscle cell proliferation, migration, and vascular remodeling.
Arteriosclerosis, thrombosis, and vascular biology - 1 Apr 2009
Meredith Dane, Panchatcharam Manikandan, Miriyala Sumitra, Tsai Yau-Sheng, Morris Andrew J, Maeda Nobuyo, Stouffer George A, Smyth Susan S
Abstract excerpt
OBJECTIVE: The peroxisome proliferator activated receptor-gamma (PPARgamma) protein is a nuclear transcriptional activator with importance in diabetes management as the molecular target for the thiazolidinedione (TZD) family of drugs. Substantial evidence indicates that the TZD family of PPARgamma agonists may retard the development of atherosclerosis. However, recent clinical data have suggested that at least...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
